Cubist Systematic Strategies’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-165,408
| Closed | -$11.7M | – | 1587 |
|
|
2025
Q1 | $11.7M | Buy |
+165,408
| New | +$11.7M | 0.07% | 188 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1559 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1541 |
|
|
2024
Q2 | – | Sell |
-47,222
| Closed | -$4.12M | – | 1548 |
|
|
2024
Q1 | $4.12M | Buy |
47,222
+19,796
| +72% | +$1.73M | 0.02% | 584 |
|
|
2023
Q4 | $2.64M | Buy |
+27,426
| New | +$2.64M | 0.02% | 706 |
|
|
2023
Q3 | – | Sell |
-199,927
| Closed | -$17.3M | – | 2021 |
|
|
2023
Q2 | $17.3M | Buy |
199,927
+171,674
| +608% | +$14.9M | 0.12% | 110 |
|
|
2023
Q1 | $2.75M | Sell |
28,253
-82,535
| -74% | -$8.03M | 0.02% | 937 |
|
|
2022
Q4 | $11.5M | Buy |
110,788
+23,590
| +27% | +$2.44M | 0.07% | 257 |
|
|
2022
Q3 | $7.39M | Buy |
87,198
+70,579
| +425% | +$5.98M | 0.04% | 539 |
|
|
2022
Q2 | $1.38M | Sell |
16,619
-147,876
| -90% | -$12.3M | 0.01% | 1868 |
|
|
2022
Q1 | $12.7M | Buy |
164,495
+71,727
| +77% | +$5.53M | 0.11% | 195 |
|
|
2021
Q4 | $8.2M | Buy |
92,768
+17,652
| +23% | +$1.56M | 0.08% | 350 |
|
|
2021
Q3 | $5.81M | Sell |
75,116
-42,900
| -36% | -$3.32M | 0.07% | 392 |
|
|
2021
Q2 | $9.85M | Buy |
118,016
+40,405
| +52% | +$3.37M | 0.11% | 219 |
|
|
2021
Q1 | $5.86M | Buy |
77,611
+54,107
| +230% | +$4.09M | 0.08% | 368 |
|
|
2020
Q4 | $2.06M | Buy |
23,504
+12,866
| +121% | +$1.13M | 0.03% | 921 |
|
|
2020
Q3 | $809K | Sell |
10,638
-3,964
| -27% | -$301K | 0.01% | 1460 |
|
|
2020
Q2 | $1.8M | Sell |
14,602
-15,543
| -52% | -$1.92M | 0.03% | 859 |
|
|
2020
Q1 | $2.55M | Sell |
30,145
-1,950
| -6% | -$165K | 0.07% | 384 |
|
|
2019
Q4 | $2.71M | Sell |
32,095
-7,323
| -19% | -$619K | 0.05% | 585 |
|
|
2019
Q3 | $2.66M | Buy |
39,418
+17,058
| +76% | +$1.15M | 0.05% | 514 |
|
|
2019
Q2 | $1.92M | Buy |
22,360
+13,869
| +163% | +$1.19M | 0.04% | 703 |
|
|
2019
Q1 | $754K | Buy |
8,491
+4,151
| +96% | +$369K | 0.02% | 918 |
|
|
2018
Q4 | $370K | Sell |
4,340
-12,391
| -74% | -$1.06M | 0.02% | 1142 |
|
|
2018
Q3 | $1.62M | Buy |
16,731
+7,431
| +80% | +$720K | 0.09% | 283 |
|
|
2018
Q2 | $876K | Buy |
9,300
+8,800
| +1,760% | +$829K | 0.04% | 537 |
|
|
2018
Q1 | $41K | Sell |
500
-3,729
| -88% | -$306K | ﹤0.01% | 1713 |
|
|
2017
Q4 | $377K | Sell |
4,229
-95
| -2% | -$8.47K | 0.02% | 1091 |
|
|
2017
Q3 | $402K | Sell |
4,324
-1,714
| -28% | -$159K | 0.02% | 956 |
|
|
2017
Q2 | $548K | Buy |
6,038
+2,263
| +60% | +$205K | 0.04% | 695 |
|
|
2017
Q1 | $331K | Buy |
3,775
+3,033
| +409% | +$266K | 0.02% | 852 |
|
|
2016
Q4 | $61K | Sell |
742
-26,168
| -97% | -$2.15M | ﹤0.01% | 1557 |
|
|
2016
Q3 | $2.49M | Sell |
26,910
-15,776
| -37% | -$1.46M | 0.16% | 136 |
|
|
2016
Q2 | $3.32M | Sell |
42,686
-28,160
| -40% | -$2.19M | 0.19% | 92 |
|
|
2016
Q1 | $5.84M | Buy |
70,846
+42,299
| +148% | +$3.49M | 0.33% | 38 |
|
|
2015
Q4 | $2.99M | Sell |
28,547
-2,659
| -9% | -$279K | 0.18% | 121 |
|
|
2015
Q3 | $3.29M | Buy |
31,206
+11,307
| +57% | +$1.19M | 0.17% | 109 |
|
|
2015
Q2 | $2.72M | Sell |
19,899
-3,236
| -14% | -$443K | 0.13% | 189 |
|
|
2015
Q1 | $2.88M | Sell |
23,135
-3,065
| -12% | -$382K | 0.14% | 165 |
|
|
2014
Q4 | $2.37M | Buy |
26,200
+25,000
| +2,083% | +$2.26M | 0.13% | 187 |
|
|
2014
Q3 | $87K | Sell |
1,200
-14,243
| -92% | -$1.03M | 0.01% | 1562 |
|
|
2014
Q2 | $961K | Buy |
+15,443
| New | +$961K | 0.06% | 492 |
|